Glenmede Trust CO Na Crispr Therapeutics Ag Transaction History

Glenmede Trust CO Na

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 16, 2022	BUY	$61.1 - $83.78 $355,052 - $486,845	5,811 New	5,811 $379,000
Q2 2022 Aug 15, 2022	SELL	$43.23 - $73.83 $171,450 - $292,809	-3,966 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $210,951 - $314,265	3,966 New	3,966 $248,000
Q4 2021 Feb 15, 2022	SELL	$70.09 - $111.29 $171,089 - $271,658	-2,441 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$100.84 - $161.89 $2,218 - $3,561	-22 Reduced 0.89%	2,441 $394,000
Q1 2021 May 18, 2021	BUY	$110.72 - $210.04 $775 - $1,470	7 Added 0.29%	2,463 $299,000
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $74,571 - $162,143	936 Added 61.58%	2,456 $375,000
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $141,300 - $181,152	-1,800 Reduced 54.22%	1,520 $126,000
Q2 2020 Aug 14, 2020	BUY	$38.5 - $76.05 $29,645 - $58,558	770 Added 30.2%	3,320 $243,000
Q4 2019 Feb 12, 2020	SELL	$36.68 - $73.13 $12,838 - $25,595	-350 Reduced 12.07%	2,550 $154,000
Q3 2019 Nov 14, 2019	SELL	$40.99 - $52.56 $127,478 - $163,461	-3,110 Reduced 51.75%	2,900 $118,000
Q2 2019 Aug 13, 2019	BUY	$35.45 - $48.2 $149,244 - $202,922	4,210 Added 233.89%	6,010 $282,000
Q4 2018 Feb 14, 2019	BUY	$22.73 - $42.34 $40,914 - $76,212	1,800 New	1,800 $51,000
Q3 2018 Nov 15, 2018	SELL	$44.35 - $65.71 $104,178 - $154,352	-2,349 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$42.62 - $73.59 $100,114 - $172,862	2,349 New	2,349 $138,000

489

57.9M

1.1M

1.9M

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.1B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

Get notified when there are updates to the investment portfolio of Glenmede Trust CO Na, based on Form 13F filings with the SEC.

Stay updated on Glenmede Trust CO Na with notifications on news.